Electromed Inc Revenue Growth Rates (ELMD), Current and Historic Growth - CSIMarket
CSIMarket
 


Electromed Inc   (NYSEAMER: ELMD)
 

ELMD's Revenue Growth by Quarter and Year

Electromed Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ELMD/growth
https://api.csimarket.com/api/v1/companies/ELMD/fundamentals
https://api.csimarket.com/api/v1/companies/ELMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ELMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 18.68
FY 18.68

ELMDs Annual Revenue
Electromed Inc 's Revenue in the fiscal year 2026 $ 73.78 millions
Electromed Inc 's Revenue in the fiscal year 2025 $ 63.97 millions
Electromed Inc 's Revenue in the fiscal year 2024 $ 54.72 millions
Electromed Inc 's Revenue in the fiscal year 2023 $ 48.07 millions
Electromed Inc 's Revenue in the fiscal year 2022 $ 41.66 millions




ELMD Revenue first quarter 2026 Y/Y Growth Comment
Electromed Inc achieved in the first quarter 2026, above Company average Revenue increase of 15.32% year on year, to $ 18.68 millions.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 97 other companies have achieved higher Revenue growth. While Electromed Inc ' s Revenue growth of 15.32% ranks overall at the positon no. 1873 in the first quarter 2026.




ELMD Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 15.32 %
FY   -

Financial Statements
Electromed Inc 's first quarter 2026 Revenue $ 18.68 millions ELMD's Income Statement
Electromed Inc 's first quarter 2025 Revenue $ 16.20 millions Quarterly ELMD's Income Statement


ELMD Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September -3.8 %
FY (Year on Year)   -




Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #98
Healthcare Sector #288
Overall #1873

Revenue Y/Y Growth Statistics
High Average Low
39.56 % 11.03 % -33.01 %
(Dec 31 2014)   (Sep 30 2013)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #98
Healthcare Sector #288
Overall #1873
Revenue Y/Y Growth Statistics
High Average Low
39.56 % 11.03 % -33.01 %
(Dec 31 2014)   (Sep 30 2013)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Electromed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
54.92 % 3.3 % -33.21 %
(Sep 30 2011)  


ELMD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Electromed Inc disclosed fall in Revenue from the fourth quarter by -3.8% to $ 18.68 millions, from $ 19.42 millions achived in the previous reporting period.

But that's not important problem, as Electromed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Electromed Inc 's Revenue growth quarter on quarter, overall rank is 823.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #124
Overall #823
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #124
Overall #823
Revenue Q/Q Growth Statistics
High Average Low
54.92 % 3.3 % -33.21 %
(Sep 30 2011)  


ELMD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Electromed Inc disclosed fall in Revenue from the fourth quarter by -3.8% to $ 18.68 millions, from $ 19.42 millions achived in the previous reporting period.

But that's not important problem, as Electromed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Electromed Inc 's Revenue growth quarter on quarter, overall rank is 823.


Electromed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 74.56
Y / Y Revenue Growth (TTM) 13.83 %
Year on Year Revenue Growth Overall Ranking # 1012
Seqeuential Revenue Change (TTM) 3.45 %
Seq. Revenue Growth (TTM) Overall Ranking # 2085


Cumulative Revenue growth Comment
Electromed Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 13.83% year on year, to $ 75 millions if the fiscal year would have ended in Sep 30 2026.
Electromed Inc 's trailing twelve months Revenue growth was higher than company's average 10.31% and higher than 12.67% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 3.45 % from $72.08 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at10.31%.

In the Healthcare sector 193 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 954 to 1012.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 194
Overall # 1012

Revenue TTM Y/Y Growth Statistics
High Average Low
28.9 %
10.31 %
-22.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2085
Cumulative Revenue growth Comment
Electromed Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 13.83% year on year, to $ 75 millions if the fiscal year would have ended in Sep 30 2026.
Electromed Inc 's trailing twelve months Revenue growth was higher than company's average 10.31% and higher than 12.67% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 3.45 % from $72.08 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at10.31%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 3.45 % increase from $72.08 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 193 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 954 to 1012.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 194
Overall # 1012

Revenue TTM Y/Y Growth Statistics
High Average Low
28.9 %
10.31 %
-22.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2085




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ELMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions
Mannkind Corporation24.04%$ 24.035 millions
Castle Biosciences Inc 23.90%$ 23.901 millions
Coherus Oncology inc 23.36%$ 23.360 millions
Prestige Consumer Healthcare Inc 22.93%$ 22.929 millions
Acadia Pharmaceuticals Inc 22.85%$ 22.847 millions
Protalix Biotherapeutics inc 22.82%$ 22.822 millions
Atrium Therapeutics Inc 22.81%$ 22.814 millions
Capsovision Inc 22.44%$ 22.443 millions
Veracyte Inc 22.10%$ 22.105 millions
Radnet Inc 22.07%$ 22.068 millions
Alkermes Plc 21.80%$ 21.804 millions
Alpha Teknova Inc 21.52%$ 21.523 millions
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions


About Electromed Inc Revenue Growth Rates (ELMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Electromed Inc (CIK 1488917).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-036166
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Electromed Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.